Descripción de la empresa
BrightSpring Health Services, Inc. operates as a comprehensive home and community-based healthcare services platform within the United States, delivering essential pharmacy and provider services that include clinical support through its two primary segments, Pharmacy Solutions and Provider Services. The company is positioned within the broader Healthcare sector, specifically functioning in the Health Information Services industry, which implies a focus on data-driven solutions and direct service delivery to improve patient outcomes outside of traditional hospital settings. On a significant scale, the organization employs approximately 23,500 individuals and reports a trailing twelve-month revenue of $12.91 billion, though its market capitalization and standard P/E metrics are currently not available in the provided financial data. The combination of substantial annual revenue and a large workforce indicates that BrightSpring Health Services holds a considerable operational footprint, suggesting the company manages complex logistics and clinical networks that serve a massive patient population across the country.
Salud financiera
The company reported a trailing twelve-month revenue of $12.91 billion, accompanied by a net income of $106.35 million and an EBITDA of $485.33 million, revealing a distinct gap between gross revenue and bottom-line profit that highlights a substantial cost structure involving operational expenses and non-operating costs. This disparity is further evidenced by a profit margin of 1.5%, which contrasts with a gross margin of 11.8% and an operating margin of 3.0%, indicating that the company faces significant overhead challenges that compress profitability before accounting for interest and taxes. The firm's free cash flow stands at -$334,849,888, signaling a period where capital expenditures or working capital requirements exceed operating cash generation, which limits immediate financial flexibility for aggressive expansion without external financing. Despite this cash burn, the company holds $88.37 million in cash against a total debt load of $2.71 billion, resulting in a debt-to-equity ratio of 143.60% that characterizes a highly leveraged balance sheet rather than a conservative one. Liquidity management is supported by a current ratio of 1.56, suggesting the company maintains sufficient short-term assets to cover its immediate liabilities, although the high leverage ratio introduces solvency risks under tightening credit conditions. Return metrics show a return on equity of 5.9% and a return on assets of 3.3%, figures that reflect the impact of the high debt levels on overall management effectiveness and the dilution of shareholder returns relative to the capital employed.
Evaluación de valoración
Trailing and forward P/E ratios are both listed as N/A in the available data, which prevents a direct comparison of expected earnings trajectories but suggests that traditional earnings-based valuation models may be less relevant given the current earnings volatility or structural reporting issues. The price-to-book ratio is recorded at 15.90, indicating that the market values the company's equity at a significant premium over its book value, likely reflecting intangible assets, brand value, or growth expectations that are not captured on the balance sheet. Alternative valuation metrics such as the EV/EBITDA of 67.28 and the unavailable price-to-sales ratio provide additional context, suggesting that the market is willing to pay a high multiple relative to the company's earnings before interest, taxes, depreciation, and amortization. The stock has traded within a range defined by a 52-week high of $151.08 and a 52-week low of $56.77, meaning the current trading price sits somewhere between these extremes, reflecting recent market volatility and investor sentiment shifts over the past year. With a beta of 2.05, the stock exhibits price volatility that is more than double that of the broader market, implying that price movements are highly sensitive to market sentiment and macroeconomic fluctuations.
Growth & Income
Revenue growth year-over-year stands at 29.3%, while earnings growth year-over-year is reported at 338.3%, demonstrating that earnings are expanding at a significantly faster rate than revenue, which often implies a one-time gain, a non-recurring event, or a temporary structural shift in cost recognition rather than sustainable organic profitability. The company offers a dividend yield of 2.3%, but the payout ratio is listed as N/A, which makes it difficult to assess the sustainability of the dividend given the recent earnings volatility and the absence of a standard payout metric. Given the high debt-to-equity ratio and negative free cash flow, the company is likely relying on retained earnings and debt financing to fund operations rather than distributing cash to shareholders for dividends. Overall, the growth and income profile presents a dichotomy of strong top-line expansion and earnings acceleration contrasted against high leverage, negative cash flow, and limited liquidity metrics that require careful monitoring by stakeholders.